The NYU Lung Cancer Biomarker Center CVC has recruited 1143 high-risk smokers (SCREENING COHORT) for the early detection of lung cancer. We have evaluated 1047 study subjects in our R/0 LUNG CANCER COHORT in collaboration with Harvey Pass, MD and the Division of Thoracic Surgery. Questionnaires, blood (100ml), spirometry, sputum, and CT-scans are obtained. 52% of the SCREENING COHORT had non-calcified nodules (NCN) with 3771 CT-Scans obtained to assess growth rates. 22 thoracic neoplasms were diagnosed with 18 lung adenocarcinomas. Biomarker collaborations with D, Sidransky Johns Hopkins) identified a panel of genes with promoter hypermethylations in plasma from lung cancer patients. Consistent with this finding, we noted increased plasma S- adenosylmethionine, a key intermediate in the methylation pathway, in lung cancer patients compared to high-risk smokers with NCN. Using set aside funds, we showed a 29-gene expression pattern in PBMC that separated lung cancer from high-risk controls with L, Showe (Wistar, UPenn), M-s Tang and colleagues demonstrated DNA adducts occurred at hot spot mutation sites in p53 and K-ras, and that poor repair contributed to adduct persistence. Exhaled breath predicted lung cancer with high AUC using combinations of alkanes measured in GC/MS. Our research plan is to expand our CVC with 300 new high-risk smokers, 1000 follow-up NCNs, and >250 lung cancers. We will evaluate NCN by CT- scans for early detection. We will determine risk for lung cancer among high-risk smokers by measuring blood acrolein DNA adducts and PBMC DNA repair capacity. We will develop a phase 3 validation case control study of 200 lung cancer cases and 200 matched controls and a phase 4 validation cohorts study of 600 high-risk smokers with >40 incident lung cancers. We will evaluate serum for tumor-associated antigens, auto-antibodies, gene expression patterns in PBMC and pathway control by microRNAs. Importantly, we will cross validate biomarker panels in the same prospective high risk smoker cohorts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA086137-14S1
Application #
8761282
Study Section
Special Emphasis Panel (ZCA1-SRLB-3 (M1))
Program Officer
Krueger, Karl E
Project Start
2014-01-16
Project End
2016-01-15
Budget Start
2014-01-16
Budget End
2016-01-15
Support Year
14
Fiscal Year
2014
Total Cost
$258,397
Indirect Cost
$101,645
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Segal, Leopoldo N; Clemente, Jose C; Wu, Benjamin G et al. (2017) Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax 72:13-22
Segal, Leopoldo N; Clemente, Jose C; Li, Yonghua et al. (2017) Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients. Cell Host Microbe 21:530-537.e4
Birse, Charles E; Tomic, Jennifer L; Pass, Harvey I et al. (2017) Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules. Clin Proteomics 14:25
Segal, Leopoldo N; Clemente, Jose C; Tsay, Jun-Chieh J et al. (2016) Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol 1:16031
Fahrmann, Johannes F; Grapov, Dmitry; DeFelice, Brian C et al. (2016) Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer. Cancer Biomark 16:609-17
Dai, Liping; Tsay, Jun-Chieh J; Li, Jitian et al. (2016) Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer 99:172-9
Wang, Jie; Shivakumar, Shilpa; Barker, Kristi et al. (2016) Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules. J Thorac Oncol 11:334-45
Vachani, Anil; Pass, Harvey I; Rom, William N et al. (2015) Validation of a multiprotein plasma classifier to identify benign lung nodules. J Thorac Oncol 10:629-37
Wu, Feng; Rom, William N; Koshiji, Minori et al. (2015) Role of GLI1 and NDRG1 in Increased Resistance to Apoptosis Induction. J Environ Pathol Toxicol Oncol 34:213-25

Showing the most recent 10 out of 46 publications